RxDoctor Payments DataLook up a doctor →

Paul Thuluvath, MD

Gastroenterology · Baltimore, MDNPI 1720019474

Payments from drug & device makers

$3,574,343in general payments, 2019–2025

Across 1,035 payments — averaging $3453.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$847K
  • Intercept Pharmaceuticals, Inc.$702K
  • Gilead$614K
  • E.r. Squibb & Sons, L.L.C.$335K
  • Madrigal Pharmaceuticals$199K
  • Exelixis Inc.$170K
  • plus $708K from 49 others
$104,932in research payments, 2019–2025

Across 23 payments — averaging $4562.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$100K
  • Ipsen Bioscience Inc.$5K
  • Eli Lilly$55

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech, Inc.46$846,573
Intercept Pharmaceuticals, Inc.147$701,896
Gilead261$614,313
E.r. Squibb & Sons, L.L.C.14$335,209
Madrigal Pharmaceuticals69$198,882
Exelixis Inc.51$169,608
Eisai Inc.28$143,385
Bausch Health US, LLC38$122,264
AbbVie(2 entities)107$98,833
Alnylam Pharmaceuticals Inc.37$70,554
Mallinckrodt Hospital Products Inc.38$69,608
Regeneron22$43,961
Pfizer10$41,434
Intercept Pharma Europe Ltd.7$40,776
Ipsen Bioscience Inc.18$37,438
Bristol Myers Squibb4$25,982
Mallinckrodt Enterprises LLC2$4,114
Shire North American Group Inc1$3,972
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC30$3,038
Takeda Pharmaceuticals U.S.A., Inc.18$397
Medtronic3$264
AstraZeneca6$220
QOL Medical, LLC6$166
Ipsen Biopharmaceuticals, Inc6$152
Shionogi Inc6$126
Phathom Pharmaceuticals, Inc.5$114
Incyte Corporation4$106
Ardelyx, Inc.4$85
Nestle Healthcare Nutrition Inc.4$67
Johnson & Johnson3$59
Olympus America Inc.3$58
Sanofi2$54
Lilly USA, LLC2$52
Romark Laboratories, LC3$48
Dynavax Technologies Corporation3$46
Aimmune Therapeutics, Inc.2$44
Novo Nordisk2$40
Ferring Pharmaceuticals Inc.2$40
Digestive Care, Inc.2$39
Amgen2$36
Ironwood Pharmaceuticals, Inc2$30
W. L. Gore & Associates, Inc.2$27
Regeneron Healthcare Solutions, Inc.1$24
Cumberland Pharmaceuticals, Inc.1$21
Redhill Biopharma Inc.1$20
Vivus LLC1$20
Albireo Pharma, Inc.1$20
Ultragenyx Pharmaceutical Inc.1$19
Daiichi Sankyo Inc.1$18
Evoke Pharma, Inc.1$18
Mirum Pharmaceuticals, Inc.1$17
Intra-sana Laboratories1$17
Dova Pharmaceuticals1$16
Endo Pharmaceuticals Inc.1$12
Ambu Inc.1$12

How this compares

$3,574,343 in reported general payments places this provider in the 95th percentile of 455 gastroenterology providers in Maryland.

See all gastroenterology providers in Maryland

Medicare billing

Part B allowed, 2024
$115,625
Medicare patients
526
Services billed
1,174

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →